The medication helped her metabolic conditions, but also appeared to reignite old restrictive patterns, prompting her to over-exercise and secretly continue dosing even after her physician stopped the prescription
NICE approved semaglutide (Wegovy) for weight management in specialist NHS weight management services in 2023 (TA875), but availability is limited to patients with: BMI 35 kg/m with at least one weight-related comorbidity, or BMI 30 kg/m with exceptional circumstances Lower BMI thresholds apply for people from some minority ethnic groups (typically 27.5 kg/m) Participation in a specialist weight management programme Treatment limited to a maximum of 2 years Access varies by region due to local integrated care board (ICB) implementation decisions and limited NHS specialist service capacity
Thyroid 34(3):295313
1 H NMR (400 MHz, DMSO-d6) = 4.78 (s, 2H), 3.52 (t, J = 7.0 Hz, 4H), 2.66 (t, J = 7.1 Hz, 4H), 1.53 (s, 6H)
10.1016/j.bbi.2018.05.005 178